c-Rel is a myeloid checkpoint for cancer immunotherapy
Li T, Li X, Zamani A, Wang W, Lee C, Li M, Luo G, Eiler E, Sun H, Ghosh S, Jin J, Murali R, Ruan Q, Shi W, Chen YH. Nat Cancer 1, 507–517(2020). doi: 10.1038/s43018-020-0061-3
Summary
Read the Department of Communications press release.
